RU2011143736A - Композиции для смягчения поражений, вызванных ультрафиолетовым излучением - Google Patents
Композиции для смягчения поражений, вызванных ультрафиолетовым излучением Download PDFInfo
- Publication number
- RU2011143736A RU2011143736A RU2011143736/15A RU2011143736A RU2011143736A RU 2011143736 A RU2011143736 A RU 2011143736A RU 2011143736/15 A RU2011143736/15 A RU 2011143736/15A RU 2011143736 A RU2011143736 A RU 2011143736A RU 2011143736 A RU2011143736 A RU 2011143736A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- composition according
- disease
- dermatitis
- photosensitive
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 35
- 230000005855 radiation Effects 0.000 title claims abstract 3
- 208000017520 skin disease Diseases 0.000 claims abstract 9
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract 7
- 229940127557 pharmaceutical product Drugs 0.000 claims abstract 6
- 206010034972 Photosensitivity reaction Diseases 0.000 claims abstract 5
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 claims abstract 4
- 208000003351 Melanosis Diseases 0.000 claims abstract 4
- 230000001684 chronic effect Effects 0.000 claims abstract 4
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims abstract 2
- 206010056951 Actinic cheilitis Diseases 0.000 claims abstract 2
- 206010004146 Basal cell carcinoma Diseases 0.000 claims abstract 2
- 208000013165 Bowen disease Diseases 0.000 claims abstract 2
- 208000019337 Bowen disease of the skin Diseases 0.000 claims abstract 2
- 206010008570 Chloasma Diseases 0.000 claims abstract 2
- XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 claims abstract 2
- ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 claims abstract 2
- 229930182847 D-glutamic acid Natural products 0.000 claims abstract 2
- 229930182820 D-proline Natural products 0.000 claims abstract 2
- 208000002506 Darier Disease Diseases 0.000 claims abstract 2
- 201000004624 Dermatitis Diseases 0.000 claims abstract 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims abstract 2
- 229930195710 D‐cysteine Natural products 0.000 claims abstract 2
- 206010014970 Ephelides Diseases 0.000 claims abstract 2
- 206010015150 Erythema Diseases 0.000 claims abstract 2
- 208000012777 Hartnup Disease Diseases 0.000 claims abstract 2
- 206010023369 Keratosis follicular Diseases 0.000 claims abstract 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-Glutamic acid Natural products OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract 2
- 206010029400 Nicotinic acid deficiency Diseases 0.000 claims abstract 2
- 208000002141 Pellagra Diseases 0.000 claims abstract 2
- 206010051246 Photodermatosis Diseases 0.000 claims abstract 2
- 241000097929 Porphyria Species 0.000 claims abstract 2
- 208000010642 Porphyrias Diseases 0.000 claims abstract 2
- 206010037083 Prurigo Diseases 0.000 claims abstract 2
- 241001303601 Rosacea Species 0.000 claims abstract 2
- 206010041303 Solar dermatitis Diseases 0.000 claims abstract 2
- 206010048218 Xeroderma Diseases 0.000 claims abstract 2
- 208000009621 actinic keratosis Diseases 0.000 claims abstract 2
- 230000001153 anti-wrinkle effect Effects 0.000 claims abstract 2
- 201000008937 atopic dermatitis Diseases 0.000 claims abstract 2
- 230000015572 biosynthetic process Effects 0.000 claims abstract 2
- 239000003795 chemical substances by application Substances 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract 2
- 239000002537 cosmetic Substances 0.000 claims abstract 2
- 201000001981 dermatomyositis Diseases 0.000 claims abstract 2
- 231100000321 erythema Toxicity 0.000 claims abstract 2
- 229960002989 glutamic acid Drugs 0.000 claims abstract 2
- 206010021198 ichthyosis Diseases 0.000 claims abstract 2
- 201000004607 keratosis follicularis Diseases 0.000 claims abstract 2
- 201000011486 lichen planus Diseases 0.000 claims abstract 2
- 206010025135 lupus erythematosus Diseases 0.000 claims abstract 2
- 208000002440 photoallergic dermatitis Diseases 0.000 claims abstract 2
- 208000017983 photosensitivity disease Diseases 0.000 claims abstract 2
- 208000007578 phototoxic dermatitis Diseases 0.000 claims abstract 2
- 201000004700 rosacea Diseases 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 206010041307 solar urticaria Diseases 0.000 claims abstract 2
- 206010041823 squamous cell carcinoma Diseases 0.000 claims abstract 2
- 230000000475 sunscreen effect Effects 0.000 claims abstract 2
- 239000000516 sunscreening agent Substances 0.000 claims abstract 2
- 208000011580 syndromic disease Diseases 0.000 claims abstract 2
- 208000002177 Cataract Diseases 0.000 claims 4
- 230000000069 prophylactic effect Effects 0.000 claims 2
- 229940126585 therapeutic drug Drugs 0.000 claims 2
- 208000010201 Exanthema Diseases 0.000 claims 1
- 241000101040 Pityriasis Species 0.000 claims 1
- 201000005884 exanthem Diseases 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 229940012356 eye drops Drugs 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 239000000049 pigment Substances 0.000 claims 1
- 206010037844 rash Diseases 0.000 claims 1
- YQNQNVDNTFHQSW-UHFFFAOYSA-N acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester Chemical compound CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C([N+]([O-])=O)S1 YQNQNVDNTFHQSW-UHFFFAOYSA-N 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Композиция для смягчения вызванного ультрафиолетовым излучением поражения, включающая одно или более соединений, выбранных из группы, состоящей из D-глутаминовой кислоты, L-глутаминовой кислоты, D-пролина, D-цистеина и L-цистеина, и их производных и/или солей.2. Композиция по п.1, причем композицию применяют в качестве состава для нанесения на кожу.3. Композиция по п.2, причем композицию применяют в качестве косметического продукта.4. Композиция по п.3, причем композиция представляет собой средство против морщин.5. Композиция по п.3, причем композиция представляет собой солнцезащитное средство.6. Композиция по п.2, причем композицию применяют в качестве фармацевтического продукта для кожного заболевания.7. Композиция по п.6, в которой кожное заболевание выбирают из группы, состоящей из эритемы, солнечного дерматита, хронической актинической дерматопатии, актинического кератоза, актинического хейлита, синдрома Фавра-Ракушо, фотодерматоза, фотоконтактного дерматита, брелокового дерматита, фоточувствительной лекарственной сыпи, полиморфной световой сыпи, световой оспы Базена, солнечной крапивницы, хронического фоточувствительного дерматита, пигментной ксеродермы, образования веснушек, порфирии, пеллагры, болезни Хартнупа, солнечного кератоза, дерматомиозита, красного плоского лишая, болезни Дарье, красного волосистого питириаза, розовых угрей, атопического дерматита, хлоазмы, подострого пруриго, красной волчанки, плоскоклеточной карциномы, базально-клеточной карциномы и болезни Боуэна.8. Композиция по п.6 или 7, в которой фармацевтический продукт для кожного заболевания представляет собой терапевтический препа�
Claims (13)
1. Композиция для смягчения вызванного ультрафиолетовым излучением поражения, включающая одно или более соединений, выбранных из группы, состоящей из D-глутаминовой кислоты, L-глутаминовой кислоты, D-пролина, D-цистеина и L-цистеина, и их производных и/или солей.
2. Композиция по п.1, причем композицию применяют в качестве состава для нанесения на кожу.
3. Композиция по п.2, причем композицию применяют в качестве косметического продукта.
4. Композиция по п.3, причем композиция представляет собой средство против морщин.
5. Композиция по п.3, причем композиция представляет собой солнцезащитное средство.
6. Композиция по п.2, причем композицию применяют в качестве фармацевтического продукта для кожного заболевания.
7. Композиция по п.6, в которой кожное заболевание выбирают из группы, состоящей из эритемы, солнечного дерматита, хронической актинической дерматопатии, актинического кератоза, актинического хейлита, синдрома Фавра-Ракушо, фотодерматоза, фотоконтактного дерматита, брелокового дерматита, фоточувствительной лекарственной сыпи, полиморфной световой сыпи, световой оспы Базена, солнечной крапивницы, хронического фоточувствительного дерматита, пигментной ксеродермы, образования веснушек, порфирии, пеллагры, болезни Хартнупа, солнечного кератоза, дерматомиозита, красного плоского лишая, болезни Дарье, красного волосистого питириаза, розовых угрей, атопического дерматита, хлоазмы, подострого пруриго, красной волчанки, плоскоклеточной карциномы, базально-клеточной карциномы и болезни Боуэна.
8. Композиция по п.6 или 7, в которой фармацевтический продукт для кожного заболевания представляет собой терапевтический препарат для кожного заболевания.
9. Композиция по п.6 или 7, в которой фармацевтический препарат для кожного заболевания представляет собой профилактическое средство для кожного заболевания.
10. Композиция по п.1, которую применяют в качестве пищевого продукта.
11. Композиция по п.1, которую применяют в качестве фармацевтического продукта для катаракты.
12. Композиция по п.11, в которой фармацевтический продукт для катаракты представляет собой терапевтический препарат для лечения катаракты или профилактическое средство против катаракты.
13. Композиция по п.11 или 12, причем композицию применяют в виде глазных капель.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009-083078 | 2009-03-30 | ||
| JP2009083078 | 2009-03-30 | ||
| JP2009-083077 | 2009-03-30 | ||
| JP2009083077 | 2009-03-30 | ||
| JP2009220983 | 2009-09-25 | ||
| JP2009-220983 | 2009-09-25 | ||
| PCT/JP2010/055648 WO2010113925A1 (ja) | 2009-03-30 | 2010-03-30 | 紫外線障害軽減組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2011143736A true RU2011143736A (ru) | 2013-05-10 |
| RU2519206C2 RU2519206C2 (ru) | 2014-06-10 |
Family
ID=42828215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011143736/15A RU2519206C2 (ru) | 2009-03-30 | 2010-03-30 | Композиции для смягчения поражений, вызванных ультрафиолетовым излучением |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8735442B2 (ru) |
| EP (1) | EP2415468B1 (ru) |
| JP (2) | JP5727364B2 (ru) |
| KR (1) | KR20120027156A (ru) |
| CN (1) | CN102365086A (ru) |
| AU (1) | AU2010231598A1 (ru) |
| BR (1) | BRPI1009796A2 (ru) |
| ES (1) | ES2638046T3 (ru) |
| RU (1) | RU2519206C2 (ru) |
| TW (1) | TWI527584B (ru) |
| WO (1) | WO2010113925A1 (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012057084A1 (ja) * | 2010-10-25 | 2012-05-03 | キリン協和フーズ株式会社 | 風味改良剤 |
| CN104363772B (zh) * | 2012-05-01 | 2019-02-12 | Mc食品科技株式会社 | 风味改良剂 |
| WO2014058084A1 (ko) * | 2012-10-09 | 2014-04-17 | 주식회사 바이오리더스 | 감마올리고펩타이드 또는 그 염을 함유하는 주름개선용 화장료 조성물 |
| JP6346596B2 (ja) * | 2015-08-31 | 2018-06-20 | 株式会社ミルボン | 毛髪変形用第１剤、及び毛髪変形処理方法 |
| WO2018114745A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Personal care compositions comprising poorly soluble compounds |
| CN110121330B (zh) | 2016-12-21 | 2022-04-29 | 联合利华知识产权控股有限公司 | 具有包含4-取代的间苯二酚和氨基酸的谷胱甘肽前体的个人护理组合物 |
| EA201991185A1 (ru) | 2016-12-21 | 2020-01-13 | Юнилевер Н.В. | Композиции для личной гигиены, содержащие цистин |
| CA3047495A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Topical skin lightening additive and composition with amino acids and nicotinamide compounds |
| EP3603612A4 (en) * | 2017-03-24 | 2020-08-12 | Ajinomoto Co., Inc. | AGENT IMPROVING THE FUNCTIONS OF THE CORNEAL LAYER |
| JP6493703B1 (ja) * | 2017-09-28 | 2019-04-03 | ウシオ電機株式会社 | 殺菌方法、殺菌装置 |
| JP7467138B2 (ja) | 2020-01-30 | 2024-04-15 | 株式会社 資生堂 | 腸管バリア改善剤 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW222591B (ru) | 1991-08-30 | 1994-04-21 | Procter & Gamble | |
| US5296500A (en) | 1991-08-30 | 1994-03-22 | The Procter & Gamble Company | Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy |
| AU675778B2 (en) * | 1991-11-27 | 1997-02-20 | Bioresearch Inc. | Specific eatable taste modifiers |
| US6197317B1 (en) * | 1997-08-11 | 2001-03-06 | Marvin E. Klein | Composition and method for the treatment of skin |
| JPH11286442A (ja) | 1998-04-01 | 1999-10-19 | Ajinomoto Co Inc | 炎症因子活性化抑制剤 |
| EP1120407B1 (en) | 1998-10-09 | 2013-02-20 | Ajinomoto Co., Inc. | Cystine derivatives |
| JP2001097888A (ja) * | 1999-09-28 | 2001-04-10 | Hiroshi Ikeno | 外用組成物 |
| JP2002047178A (ja) * | 2000-08-03 | 2002-02-12 | Noevir Co Ltd | Ｉ型マトリックスメタロプロテアーゼ産生阻害剤 |
| JP3983003B2 (ja) * | 2001-03-15 | 2007-09-26 | 株式会社ファンケル | グルタチオン増強用組成物 |
| EP1521735A2 (en) | 2001-05-25 | 2005-04-13 | Ceremedix, Inc | Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| WO2003088909A2 (en) | 2002-04-19 | 2003-10-30 | University Of Arizona | Methods for modulating phototoxicity |
| JP2005343880A (ja) * | 2004-06-02 | 2005-12-15 | Ito:Kk | レドックス制御組成物 |
| EP1815245B1 (en) | 2004-11-15 | 2010-04-21 | Erasmus MC | Prematurely ageing mouse models for the role of dna damage in ageing and intervention in ageing-related pathology |
| KR100628413B1 (ko) * | 2005-12-29 | 2006-09-26 | 주식회사 바이오리더스 | 폴리감마글루탐산―비타민ｃ 복합체를 함유하는 콜라게나제저해제 및 그 용도 |
| US20080070993A1 (en) * | 2006-09-07 | 2008-03-20 | Janos Borbely | Additives for cosmetic products and the like |
| JP4980740B2 (ja) | 2007-01-31 | 2012-07-18 | 株式会社 資生堂 | ２次元液体クロマトグラフィー分析方法および分取用流路切り替えユニット |
| JP2008285472A (ja) * | 2007-04-16 | 2008-11-27 | Sapporo Breweries Ltd | 細胞外マトリックス分解酵素阻害剤 |
| DE102007038413A1 (de) * | 2007-08-09 | 2009-02-12 | Beiersdorf Ag | Kosmetische Emulgatorkombination |
-
2010
- 2010-03-30 KR KR1020117024676A patent/KR20120027156A/ko unknown
- 2010-03-30 AU AU2010231598A patent/AU2010231598A1/en not_active Abandoned
- 2010-03-30 BR BRPI1009796A patent/BRPI1009796A2/pt not_active Application Discontinuation
- 2010-03-30 RU RU2011143736/15A patent/RU2519206C2/ru not_active IP Right Cessation
- 2010-03-30 TW TW099109837A patent/TWI527584B/zh not_active IP Right Cessation
- 2010-03-30 ES ES10758696.8T patent/ES2638046T3/es active Active
- 2010-03-30 WO PCT/JP2010/055648 patent/WO2010113925A1/ja active Application Filing
- 2010-03-30 EP EP10758696.8A patent/EP2415468B1/en active Active
- 2010-03-30 CN CN2010800141315A patent/CN102365086A/zh active Pending
- 2010-03-30 JP JP2011507201A patent/JP5727364B2/ja not_active Expired - Fee Related
- 2010-03-30 US US13/138,786 patent/US8735442B2/en active Active
-
2015
- 2015-02-25 JP JP2015035898A patent/JP5934405B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2415468A1 (en) | 2012-02-08 |
| WO2010113925A1 (ja) | 2010-10-07 |
| CN102365086A (zh) | 2012-02-29 |
| US20120142941A1 (en) | 2012-06-07 |
| US8735442B2 (en) | 2014-05-27 |
| EP2415468A4 (en) | 2014-08-20 |
| JP2015134790A (ja) | 2015-07-27 |
| BRPI1009796A2 (pt) | 2016-08-23 |
| TWI527584B (zh) | 2016-04-01 |
| JP5727364B2 (ja) | 2015-06-03 |
| ES2638046T3 (es) | 2017-10-18 |
| KR20120027156A (ko) | 2012-03-21 |
| AU2010231598A1 (en) | 2011-11-10 |
| JP5934405B2 (ja) | 2016-06-15 |
| RU2519206C2 (ru) | 2014-06-10 |
| EP2415468B1 (en) | 2017-07-05 |
| JPWO2010113925A1 (ja) | 2012-10-11 |
| TW201039858A (en) | 2010-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011143736A (ru) | Композиции для смягчения поражений, вызванных ультрафиолетовым излучением | |
| JP6818792B2 (ja) | メラニン改変組成物および使用方法 | |
| RU2012108105A (ru) | Композиция для уменьшения повреждения, вызванного уф-излучением | |
| RU2503443C2 (ru) | Средства против морщин | |
| EA201171197A8 (ru) | Замещенные производные азоантрацена, фармацевтические композиции и способы их применения | |
| JP7315302B2 (ja) | 皮膚外用組成物 | |
| JP7149851B2 (ja) | 皮膚外用組成物 | |
| BR112015000106A2 (pt) | moduladores heterocíclicos de síntes de lipídio | |
| MX2014004479A (es) | Derivados de oxazina novedosos y su uso en el tratamiento de enfermedades. | |
| EA201400067A1 (ru) | Новая терапевтическая композиция, содержащая апоморфин в качестве активного ингредиента | |
| EA201000362A1 (ru) | Производные 1,3-дигидроизоиндола | |
| EA201201239A1 (ru) | Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением | |
| CA2724007A1 (en) | Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention | |
| BR112012006979A2 (pt) | composição antioxidante | |
| JP5799148B2 (ja) | 新規ベンジリデンアゾリジン誘導体またはその塩を含む皮膚外用組成物 | |
| HRP20191256T1 (hr) | Pripravak koji sadrži melatonin ili njegove derivate uz koenzim q10, te njegova upotreba protiv starenja kože | |
| US20070092578A1 (en) | Skin rejuvinating supplement | |
| ES2665011T3 (es) | Composición farmacéutica para la prevención y el tratamiento de trastornos degenerativos de la piel especialmente producidos por radiaciones ionizantes | |
| JP2014114234A (ja) | 皮膚外用剤 | |
| JP2014169260A (ja) | 化粧料 | |
| JP6284729B2 (ja) | 外用組成物 | |
| UA62758U (ru) | Препарат "аромадент плюс" в виде геля для лечения и профилактики воспалительных заболеваний пародонта | |
| KR101339369B1 (ko) | 5-아미노레블린산 및 비타민씨 복합체를 함유하는 화장품 조성물 | |
| RU2011143735A (ru) | Средство для отбеливания кожи и косметический способ отбеливания кожи | |
| ES2700426T3 (es) | Compuestos derivados del ácido 3-(alquiltio)propenoico, y su aplicación en cosmética |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20210331 |